AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CLOPIDOGREL BISULPHATE

9 registrations across 3 African markets— 9 active

Markets with CLOPIDOGREL BISULPHATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
PLASEP
TABLET, COATED; ORAL
🇿🇼ZimbabweMSN LABORATORIES PRIVATE LIMITEDactiveDec 2030
CLOPIDOGREL TABLETS🇬🇭GhanaactiveJul 2028
CLOPIDOGREL TABLETS🇬🇭GhanaactiveJul 2028
DEPLATT
TABLET, COATED; ORAL
🇿🇼ZimbabweTORRENT EXPORTS LTDactiveDec 2027
CLOPI 75
TABLET, COATED; ORAL
🇿🇼ZimbabweMACLEODS PHARMACEUTICALS LIMITEDactiveDec 2027
CLOPIDOGREL BISULPHATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaCIPLA LTD.active
CLOPIDOGREL BISULPHATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaCIPLA LTD.active
CLOPIDOGREL BISULPHATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaCIPLA LTD.active
CLOPIDOGREL BISULPHATE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaCIPLA LTD.active

CLOPIDOGREL BISULPHATE in Africa — Regulatory Overview

CLOPIDOGREL BISULPHATE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Zimbabwe, Ghana. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.